Chemicals & Petrochemicals
Valuation | |
|---|---|
| Market Cap | 8.26 kCr |
| Price/Earnings (Trailing) | 45.31 |
| Price/Sales (Trailing) | 5.21 |
| EV/EBITDA | 25.95 |
| Price/Free Cashflow | 45.77 |
| MarketCap/EBT | 33.86 |
| Enterprise Value | 8.23 kCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 1.58 kCr |
| Rev. Growth (Yr) | -6.4% |
| Earnings (TTM) | 182.16 Cr |
| Earnings Growth (Yr) | -9.5% |
Profitability | |
|---|---|
| Operating Margin | 15% |
| EBT Margin | 15% |
| Return on Equity | 12.62% |
| Return on Assets | 10.31% |
| Free Cashflow Yield | 2.18% |
Growth & Returns | |
|---|---|
| Price Change 1W | 0.40% |
| Price Change 1M | -9.1% |
| Price Change 6M | -16.6% |
| Price Change 1Y | -18.3% |
| 3Y Cumulative Return | -16.4% |
| 5Y Cumulative Return | 1.1% |
| 7Y Cumulative Return | 27.3% |
| 10Y Cumulative Return | 26.8% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | -195.54 Cr |
| Cash Flow from Operations (TTM) | 263.1 Cr |
| Cash Flow from Financing (TTM) | -49.15 Cr |
| Cash & Equivalents | 24.85 Cr |
| Free Cash Flow (TTM) | 215.41 Cr |
| Free Cash Flow/Share (TTM) | 42.12 |
Balance Sheet | |
|---|---|
| Total Assets | 1.77 kCr |
| Total Liabilities | 323.83 Cr |
| Shareholder Equity | 1.44 kCr |
| Current Assets | 586.45 Cr |
| Current Liabilities | 184.71 Cr |
| Net PPE | 1.04 kCr |
| Inventory | 151.75 Cr |
| Goodwill | 0.00 |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.00 |
| Debt/Equity | 0.00 |
| Interest Coverage | 145.9 |
| Interest/Cashflow Ops | 158.54 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 10 |
| Dividend Yield | 0.62% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | 0.10% |
Summary of Alkyl Amines Chemicals's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Last updated:
Management Outlook:
Alkyl Amines expects FY25 to improve, driven by stable pharma demand, volume growth, and better margins due to raw material cost stabilization. The ethylamines plant (100 tons/day), now the world's largest, is fully operational, addressing long-term capacity needs. While FY24 saw mixed results (sub-10% volume growth, price pressures from Chinese competition), margins improved in Q4. Acetonitrile faces pricing challenges (55"“60% utilization), but cost advantages may sustain competitiveness. Anti-dumping filings for acetonitrile (potential 15"“20% injury relief by FY25 Q4) and stabilizing ethylamine/methylamine prices offer optimism.
Key Highlights:
Last updated:
Question 1 (Nilesh Ghuge, HDFC Securities):
"My first question is on capex. As you mentioned, that you commissioned this ethylamine plants during this fiscal. So can you just tell us how much total capex we incurred in FY '24? And then can you give us the project-wise breakup for that?"
Answer:
Total FY24 capex was ~Rs.120 crore, including routine maintenance, solar plants, and the ethylamine project. The ethylamine plant (100 tons/day) was capitalized at ~Rs.375 crore but incurred Rs.120 crore in FY24. Utilization of the acetonitrile plant was ~55% in H2FY24 due to Chinese competition, though pricing stabilized in Q4.
Question 2 (Nilesh Ghuge, HDFC Securities):
"And sir, just on the ethylamine side...what was the utilization of your ethylamine plant including new capacity?"
Answer:
The new ethylamine plant ran at ~60% utilization in H2FY24, with raw material (ethanol) prices softening. Margins improved due to price stabilization and lower input costs.
Question 3 (Neerav Gimudia, Anvil Research):
"Sir, I have two, three questions. One is on the volume growth for FY '24...if you can just let us know what was the volume growth for FY '24."
Answer:
FY24 volume growth was <10% (~97K tons). H2 was weaker than H1 due to Chinese competition in acetonitrile and monoisopropylamine (MIPA).
Question 4 (Neerav Gimudia, Anvil Research):
"Sir, if you can just walk us through the demand outlook for methylamines..."
Answer:
Methylamines derivatives (e.g., pharma/personal care) grow faster than base methylamines (low single-digit growth). 30% of methylamines are consumed internally; 70% sold externally.
Question 5 (Neerav Gimudia, Anvil Research):
"Any volume growth guidance which you can give for FY '25?"
Answer:
Expect 10"“15% volume growth in FY25, aided by derivatives like diethylketone (DEK), though DEK utilization was only ~20"“30% in FY24.
Question 6 (Jaiveer Shekhawat, Ambit Capital):
"First question is on the anti-dumping duty investigation...what kind of volume or margin benefit you expect?"
Answer:
Anti-dumping duty on acetonitrile (if approved by Q4FY25) may address 15"“20% injury margins. Current acetonitrile prices (Rs.150/kg) are stable but under Chinese pressure.
Question 7 (Jaiveer Shekhawat, Ambit Capital):
"When do you think you can reach back to the 25% EBITDA margin level?"
Answer:
EBITDA margins are unlikely to revisit FY21 highs (COVID-driven). Target 20"“22% margins through volume growth, as realizations stabilize post ~20% YoY decline in FY24.
Question 8 (Rajiv Rupani, Individual Investor):
"Our competitor has a 48,000 ton plant...what would be the impact on prices?"
Answer:
Balaji's methylamine expansion (40K tons) may pressure prices. Alkyl plans to convert its old ethylamine plant to methylamine to meet future demand.
Question 9 (Aman Choudhary, Motilal Oswal):
"What is the current prices of ammonia, acetic acid and methanol?"
Answer:
Ammonia: Rs.50"“52/kg; acetic acid: ~Rs.40/kg; methanol: <Rs.30/kg.
Question 10 (Dhruv, HDFC AM):
"What is the market size of Acetonitrile and how much is imported?"
Answer:
Acetonitrile market: 30K"“35K tons annually. ~50% imported (mostly from China). Domestic capacity utilization: ~55"“60% in FY24.
Understand Alkyl Amines Chemicals ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| YOGESH MATHRADAS KOTHARI | 57.62% |
| NIYOKO TRADING AND CONSULTANCY LLP | 3.83% |
| PURJEEKO TRADING & CONSULTANCY LLP | 3.81% |
| NINI YOGESH KOTHARI | 2.48% |
| SYK TRADING AND CONSULTANCY LLP | 1.54% |
| IKIGAI EMERGING EQUITY FUND | 1.36% |
| HEMENDRA MATHRADAS KOTHARI | 1.04% |
| SUNEET YOGESH KOTHARI | 0.75% |
| ANJYKO INVESTMENTS PVT LTD | 0.26% |
| KUNJLATA N SHAH | 0.15% |
| DEVANGANA JAYANT DESAI | 0.15% |
| SHUCHI HEMENDRA KOTHARI | 0.14% |
| ADITI KOTHARI DESAI | 0.14% |
| ANJALI Y KOTHARI | 0.12% |
Distribution across major stakeholders
Distribution across major institutional holders
Detailed comparison of Alkyl Amines Chemicals against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| VINATIORGA | Vinati Organics | 16.56 kCr | 2.3 kCr | -4.10% | -12.70% | 37.99 | 7.2 | - | - |
| CLEAN | Clean Science and Technology | 9.66 kCr | 1.03 kCr | -1.40% | -36.20% | 36.4 | 9.38 | - | - |
| SUDARSCHEM | Sudarshan Chemical Indus. | 7.74 kCr | 6.99 kCr | -4.90% | -13.20% | 46.05 | 1.11 | - | - |
| GALAXYSURF | Galaxy Surfactants | 7.03 kCr | 4.82 kCr | -7.60% | -28.80% | 24.56 | 1.46 | - | - |
| BALAMINES | Balaji Amines | 3.65 kCr | 1.4 kCr | -8.40% | -44.10% | 25.03 | 2.61 | - | - |
Comprehensive comparison against sector averages
ALKYLAMINE metrics compared to Chemicals
| Category | ALKYLAMINE | Chemicals |
|---|---|---|
| PE | 44.8 | 47.0 |
| PS | 5.16 | 4.29 |
| Growth | 4.6 % | 7.8 % |
Alkyl Amines Chemicals is a prominent player in the specialty chemicals sector, with the stock ticker ALKYLAMINE.
The company, which boasts a market capitalization of Rs. 9,153.3 Crores, specializes in the manufacture and supply of amines, amine derivatives, and other specialty chemicals, both in India and internationally.
Their product offerings include a wide range of aliphatic amine products such as:
Additionally, they produce various amine derivatives, including:
The company also provides specialty chemicals like acetonitrile and several other complex organic compounds. Alkyl Amines Chemicals serves diverse industries, including pharmaceuticals, agrochemicals, water treatment, and rubber chemicals.
Founded in 1979 and headquartered in Navi Mumbai, India, Alkyl Amines has shown resilience with a trailing 12 months revenue of Rs. 1,565.5 Crores.
The company not only focuses on growth—reporting a revenue increase of 3.6% over the past three years—but also delivers value to its investors by distributing a dividend yield of 1.14% per year. It's worth noting that the firm diluted its shareholder equity by 0.1% over the last three years, although it remains a profitable entity, with a profit of Rs. 178.5 Crores in the last four quarters.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
ALKYLAMINE vs Chemicals (2021 - 2025)